MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/10428194.2023.2280886

Медицинская библиотека · Leukemia & lymphoma · 2024

The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.

El-Ashwah Shaimaa, Salmanton-García Jon, Bilgin Yavuz M, Itri Federico, Žák Pavel, Weinbergerová Barbora, Verga Luisa, Omrani Ali S, Silva Maria Gomes da, Szotkowski Tomáš, Marchetti Monia, Buquicchio Caterina, Nucci Marcio, Schönlein Martin, Farina Francesca, Besson Caroline, Prezioso Lucia, Nizamuddin Summiya, Dávila-Valls Julio, Martín-Pérez Sonia, Bonuomo Valentina, Van Doesum Jaap, Tisi Maria Chiara, Passamonti Francesco, Méndez Gustavo-Adolfo, Meers Stef, Maertens Johan, López-García Alberto, Glenthøj Andreas, Bonnani Matteo, Rinaldi Ikhwan, Ormazabal-Vélez Irati, Labrador Jorge, Kulasekararaj Austin, Espigado Ildefonso, Demirkan Fatih, De Jonge Nick, Collins Graham P, Calbacho Maria, Blennow Ola, Al-Khabori Murtadha, Adžić-Vukičević Tatjana, Arellano Elena, Mišković Bojana, Mladenović Miloš, Nordlander Anna, Ráčil Zdeněk, Ammatuna Emanuele, Cordoba Raul, Hersby Ditte Stampe, Gräfe Stefanie, Emarah Ziad, Hanakova Michaela, Sacchi Maria Vittoria, Ijaz Marriyam, Rahimli Laman, Nunes Rodrigues Raquel, Zambrotta Giovanni Paolo Maria, Marchesi Francesco, Cornely Oliver A, Pagano Livio

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Since the beginning of the COVID-19 pandemic, there has been an overall improvement in patient mortality. However, haematological malignancy patients continue to experience significant impacts from COVID-19, including high rates of hospitalization, intensive care unit (ICU) admissions, and mortality. In comparison to other haematological malignancy patients, individuals with chronic myeloid leukemia (CML) generally have better prognosis. This study, conducted using a large haematological malignancy patient database (EPICOVIDEHA), demonstrated that the majority of CML patients experienced mild infections. The decline in severe and critical infections over the years can largely be attributed to the widespread administration of vaccinations and the positive response they elicited. Notably, the mortality rate among CML patients was low and exhibited a downward trend in subsequent years. Importantly, our analysis provided confirmation of the effectiveness of vaccinations in CML patients.

Для цитирования: El-Ashwah Shaimaa, Salmanton-García Jon, Bilgin Yavuz M, Itri Federico, Žák Pavel, Weinbergerová Barbora, Verga Luisa, Omrani Ali S, Silva Maria Gomes da, Szotkowski Tomáš, Marchetti Monia, Buquicchio Caterina, Nucci Marcio, Schönlein Martin, Farina Francesca, Besson Caroline, Prezioso Lucia, Nizamuddin Summiya, Dávila-Valls Julio, Martín-Pérez Sonia, Bonuomo Valentina, Van Doesum Jaap, Tisi Maria Chiara, Passamonti Francesco, Méndez Gustavo-Adolfo, Meers Stef, Maertens Johan, López-García Alberto, Glenthøj Andreas, Bonnani Matteo, Rinaldi Ikhwan, Ormazabal-Vélez Irati, Labrador Jorge, Kulasekararaj Austin, Espigado Ildefonso, Demirkan Fatih, De Jonge Nick, Collins Graham P, Calbacho Maria, Blennow Ola, Al-Khabori Murtadha, Adžić-Vukičević Tatjana, Arellano Elena, Mišković Bojana, Mladenović Miloš, Nordlander Anna, Ráčil Zdeněk, Ammatuna Emanuele, Cordoba Raul, Hersby Ditte Stampe, Gräfe Stefanie, Emarah Ziad, Hanakova Michaela, Sacchi Maria Vittoria, Ijaz Marriyam, Rahimli Laman, Nunes Rodrigues Raquel, Zambrotta Giovanni Paolo Maria, Marchesi Francesco, Cornely Oliver A, Pagano Livio. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.. Leukemia & lymphoma. 2024. DOI: 10.1080/10428194.2023.2280886.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.